{"raw_mentions": "high RET and/or BTK kinase inhibitory Activity preferred compounds of the invention show an IC50 of 0.1nM to 1. Mu.M, e.g. 0.1nM to 0.1. Mu.M in assay experiments;"}
{"final_json": [{"molecule_name": "compounds of the invention", "protein_target_name": "RET and/or BTK kinase", "binding_metric": "IC50", "value": "0.1nM to 1. Mu.M", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe final concentrations of panobinostat were 100, 30, 10, 3, 1, 0.3, 0.1, 0.03, 0.01 nanomoles per liter, for a total of 200 microliters of medium with a DMSO content of 1%; \nThe final concentrations of 10, 3, 1, 0.3, 0.1, 0.03, 0.01, 0.003, 0.001 micromoles per liter, \n\n\nNote that there are limited relevant sentences in the provided text snippet. If you need more information or context, please provide the full text."}
{"final_json": [{"molecule_name": "panobinostat", "protein_target_name": null, "binding_metric": null, "value": "100, 30, 10, 3, 1, 0.3, 0.1, 0.03, 0.01", "unit": "nanomoles per liter", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "10, 3, 1, 0.3, 0.1, 0.03, 0.01, 0.003, 0.001", "unit": "micromoles per liter", "is_logarithmic": false}]}
